Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 11, 2022
Last action Jan 11, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 11, 2022
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
3 primary · 8 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Annette Quijano
DDemocratic
P
Clinton Calabrese
DDemocratic
P
Robert Karabinchak
DDemocratic
Co
Britnee Timberlake
DDemocratic
Co
DR
Daniel R. Benson
DDemocratic
Co
MM
Mila M. Jasey
DDemocratic
Co
Pam Lampitt
DDemocratic
Co
Roy Freiman
DDemocratic
Co
TP
Thomas P. Giblin
DDemocratic
Co
Verlina Reynolds-Jackson
DDemocratic
Co
Wayne DeAngelo
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 553
Scope: NJ
Hi! I can help you understand A 553. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline